MedPath

Effect of probiotics and/or synbiotics on intestinal environment in healthy adults.

Not Applicable
Conditions
Healthy adults
Registration Number
JPRN-UMIN000029088
Lead Sponsor
Ezaki Glico Co., Ltd
Brief Summary

1. The intestinal microbiota is modulated. 2. The Faecalibacterium ratio, Bifidobacterium ratio and number, as well as the amount of short-chain fatty acid in feces increase. 3. The effect on intestinal microbiota varies depending on the number of ingested bacteria.

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
63
Inclusion Criteria

Not provided

Exclusion Criteria

1. Subjects regularly use intestinal drugs and laxatives (including strong laxatives). 2. Subjects habitually consume higher amount of alcohol. 3. Subjects who can't stop intake food containing bifidobacteria, and/or enhanced with oligosaccharide, dietary fiber during this study. 4. Subjects who have serious diseases requiring an urgent treatment, or who accept severe complication. 5. Subjects who have a medical history of diseases or surgeries affecting digestion, absorption and bowel movement. 6. Subjects who have allergy to test food. 7. Subjects who is pregnant or willing to be pregnant or breast-feeding during this study. 8. Subjects who are participated in other clinical trials that intake/apply any of food, drug, and cosmetics.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
16S rRNA gene based metagenome analysis of gut microbiome
Secondary Outcome Measures
NameTimeMethod
Fecal short chain fatty acid concentration, fecal bifidobacteria, defecation frequency
© Copyright 2025. All Rights Reserved by MedPath